Lauren Meyers to Cost-Benefit Analysis
This is a "connection" page, showing publications Lauren Meyers has written about Cost-Benefit Analysis.
Connection Strength
0.210
-
Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. Lancet Public Health. 2021 03; 6(3):e184-e191.
Score: 0.107
-
The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco. BMC Med. 2018 04 24; 16(1):58.
Score: 0.088
-
Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine. 2013 Aug 20; 31(37):3957-61.
Score: 0.016